Effect of glomerular filtration rate and proteinuria on medical cost among screened subjects
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Chronic kidney disease is a predictor of end-stage renal disease (ESRD) and cardiovascular disease (CVD). Therefore, the medical expenses are higher with the decrease in glomerular filtration rate (GFR). However, few studies have examined the medical expenses according to the baseline GFR.
We investigated the relationship between GFR at health checks and medical expenses, combining the registries of both the health checks and report of medical expenses (receipts). The health checks were done from April 2008 to March 2009, and the eligible subjects were covered by the Okinawa Branch of the Japan Health Insurance Association. All reports of medical expenses were reviewed from April 2008 to March 2010 (24 months).
A total of 74,354 subjects, 38.2 % females with the mean age of 48.1 years, were examined according to whether they had visited medical facilities during the study period. The total number of receipts was 773,276. The average receipt point, 1 point = 10 Yen, was 686,410 (eGFR < 15), 56,408 (eGFR 15–29), 47,263 (eGFR 30–44), 24,372 (45–59), 16,018 (eGFR 60–74), 13,893 (eGFR 75–89), 13,990 (eGFR 90–104), 14,717 (eGFR 105–119), and 19,139 (eGFR 120 and over), respectively. The relationship between eGFR and medical expense was U-shaped, and the expense was lowest at eGFR 75–89.
We demonstrate that the medical expenses increase as eGFR decreases. Subjects with higher eGFR, 120 and over, seemed to have higher medical expenses.
- Wen CP, Cheng TYD, Tsai MK, et al. All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462293 adults in Taiwan. Lancet. 2008;371:2173–82. CrossRef
- Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–305. CrossRef
- Levey AS, de Jong PE, Coresh J, et al. The definition, classification and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int. 2011;80:17–28. CrossRef
- Boulware LE, Jaar BG, Tarver-Carr ME, Brancati FL, Powe NR. Screening for proteinuria in US adults: a cost-effectiveness analysis. JAMA. 2003;290:3101–14. CrossRef
- Yamagata K, Iseki K, Nitta K, et al. Chronic kidney disease perspectives in Japan and the importance of urinalysis screening. Clin Exp Nephrol. 2008;12:1–8. CrossRef
- Imai E, Yamagata K, Iseki K, et al. Kidney disease screening program in Japan: history, outcome, and perspectives. Clin J Am Soc Nephrol. 2007;2:1360–6. CrossRef
- Chrysochou C, Kalra PA. Epidemiology and natural history of atherosclerotic renovascular disease. Prog Cardiovasc Dis. 2009;52:184–95. CrossRef
- Japanese Society for Dialysis Therapy. An overview of regular dialysis treatment in Japan as of Dec. 31, 2005. Tokyo: Japanese Society for Dialysis Therapy; 2006.
- Chronic Kidney Disease Prognosis Consortium. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010;375:2073–81. CrossRef
- Kondo M, Yamagata K, Hoshi SL, et al. Cost-effectiveness of chronic kidney disease mass screening test in Japan. Clin Exp Nephrol. 2012;16:279–91. CrossRef
- Matsuo S, Imai E, Horio M, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982–92. CrossRef
- Iseki K, Iseki C, Ikemiya Y, Fukiyama K. Risk of developing end-stage renal disease in a cohort of mass screening. Kidney Int. 1996;49:800–5. CrossRef
- Iseki K. Role of urinalysis in the diagnosis of chronic kidney disease (CKD). Jap Med Assoc J. 2011;54:27–30.
- Meguid El Nahas A, Bello AK. Chronic kidney disease: the global challenge. Lancet. 2005;365: 331–40.
- Yamagata K, Makino H, Akizawa T, Advisory Committee for FROM-J, et al. Design and methods of a strategic outcome study for chronic kidney disease: frontier of Renal Outcome Modifications in Japan. Clin Exp Nephrol. 2010;14:144–51. CrossRef
- Brenner BM, Lawler EV, Mackenzie HS. The hyperfiltration theory; a paradigm shift in nephrology. Kidney Int. 1996;49:1774–7. CrossRef
- Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008;358:580–91. CrossRef
- Effect of glomerular filtration rate and proteinuria on medical cost among screened subjects
Clinical and Experimental Nephrology
Volume 17, Issue 3 , pp 372-378
- Cover Date
- Print ISSN
- Online ISSN
- Springer Japan
- Additional Links
- Medical cost
- Industry Sectors
- Author Affiliations
- 1. Dialysis Unit, University Hospital of the Ryukyus, Okinawa, 903-0215, Japan
- 2. Department of Biostatistics/Epidemiology and Preventive Health Sciences, School of Health Sciences and Nursing, University of Tokyo, Tokyo, Japan
- 3. Fukushima Medical University, Fukushima, Japan